Skip to content
drillr.ai

AVAH

Aveanna Healthcare Holdings Inc.

NASDAQ · USHealthcareMedical - Care Facilities
$9.69+0.00%

Price as of Jul 20, 2026

AVAH analysis

Aveanna Healthcare Holdings Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

  1. Research

    CMS Proposes 6.4% Home Health Cut — Three Operators Most at Risk

    CMS has proposed a 6.4% aggregate payment cut for home health agencies in CY2026, creating material risk for operators with high Medicare home health exposure. Aveanna Healthcare (AVAH) faces the greatest financial risk due to 5.1x debt/EBITDA leverage and thin interest coverage, while Ensign Group (ENSG) is best positioned to absorb the impact given its SNF-dominated revenue mix and strong growth trajectory. Amedisys (AMED), now part of Optum/UnitedHealth, is no longer independently exposed.

  2. Research

    Can home health companies offset the CMS 6.4% cut through volume growth and labor efficiency?

    The CMS 6.4% home health payment cut for CY2026 represents a manageable headwind for leading operators. Aveanna Healthcare's 22% revenue growth, expanding preferred payer network of 30 agreements, and EBITDA margin recovery from 2.1% to over 12% provide substantial buffer, while Ensign Group's acquisition-driven 19% growth and all-time high occupancy rates insulate its primarily skilled nursing business. The effective revenue impact — estimated at 2–3% for diversified operators — appears absorbable, though compounding Medicaid rate pressure remains the key risk to watch.

  3. Research

    If CMS finalizes the 6.4% home health payment cut, which operators face the steepest margin compression?

    Among publicly traded operators, Aveanna Healthcare (AVAH) faces the steepest margin compression from a potential 6.4% CMS home health payment cut, given its leveraged balance sheet (5.1x debt/EBITDA) and thin free cash flow ($26M), despite home health representing only ~10% of revenue. Ensign Group has minimal direct exposure as a SNF-focused operator, while Sotera Health has no home health revenue and Amedisys was acquired by UnitedHealth in 2024.

  4. Research

    What integration risks does Aveanna face with Family First given its leveraged balance sheet?

    Aveanna Healthcare's agreement to acquire Family First Homecare layers additional integration complexity onto a balance sheet carrying $1.35 billion in debt at 4.5x net leverage, with the Thrive Skilled Pediatric Care integration still completing. While operating momentum is strong — with 2025 adjusted EBITDA guidance raised to >$300 million — interest coverage of just 1.6x and potential revolver covenant triggers leave limited margin for execution missteps during parallel integrations.

  5. Research

    How does Family First Homecare's margin profile compare to Aveanna's existing segments?

    Aveanna Healthcare's three segments show wide margin dispersion — PDS at ~29-31% gross margin, HHH at ~54%, and MS at ~45%. Family First Homecare, as a pediatric PDN operator, would flow into the PDS segment and likely carries gross margins in the 28-32% range based on the Thrive Skilled Pediatrics acquisition precedent. The real accretion opportunity lies in leveraging Aveanna's 30 preferred payer agreements and corporate infrastructure to compress the target's standalone SG&A.